Sonaris

Company Overview

Snapshot

Founded in March 2016 by Samer Toume and Avinoam Bar-Zion, Sonaris operated with 1–10 employees. The company raised $700K across two funding rounds from two investors. In April 2019, Sonaris participated in the TMCx accelerator program, a significant milestone for its US market entry strategy.

Business overview

Sonaris developed an AI-guided system designed to enable clinics to perform automated ultrasound diagnostic imaging without requiring specialized technical expertise. This automated diagnostic imaging system aimed to streamline the diagnosis workflow, create new revenue streams for clinics, and enhance patient experience and compliance. The system was intended to offer a suite of diagnostic tests, with an initial focus on screening for abdominal aortic aneurysms, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics.

Strategic signal

In April 2019, Sonaris's participation in the TMCx accelerator program signaled a strategic move towards expanding its reach into the US market. This engagement with a prominent accelerator indicated a validation of its AI-guided ultrasound technology and a proactive approach to securing partnerships and further development opportunities in a key healthcare market.

Company Intelligence Q&A

What is Sonaris's primary focus?

Sonaris focuses on developing an AI-guided ultrasound imaging system designed to automate diagnostic imaging for clinics, aiming to improve workflow efficiency and patient care.

When was Sonaris founded?

Sonaris was founded in March 2016.

Who are the founders of Sonaris?

Sonaris was co-founded by Samer Toume and Avinoam Bar-Zion.

What was a key strategic development for Sonaris in 2019?

In April 2019, Sonaris participated in the TMCx accelerator program, which was a significant step for its US market entry strategy.

What is the status of Sonaris?

Sonaris is currently non-active, having ceased operations in December 2020.